Streamline Health Solutions (NASDAQ:STRM) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Thursday morning. The firm issued a sell rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ:STRM opened at $3.50 on Thursday. The firm’s fifty day moving average is $2.65 and its 200-day moving average is $5.20. Streamline Health Solutions has a 52 week low of $1.85 and a 52 week high of $9.75. The firm has a market cap of $14.78 million, a PE ratio of -0.71 and a beta of 1.67. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.